APPLICATION
ANDA216057
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
SITAGLIPTINNone (Tentative Approval)
SITAGLIPTIN 50MG · TABLET
SITAGLIPTINNone (Tentative Approval)
SITAGLIPTIN 100MG · TABLET
SITAGLIPTINNone (Tentative Approval)
SITAGLIPTIN 25MG · TABLET
Approval history
2025-11-12UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.